Beyond the Coverage Question: A New Playbook for Cardiometabolic Care

Thursday, October 22, 2026 • 11:00 AM PT / 2:00 PM ET

Many 2027 benefits conversations about GLP-1s are still stuck on the “cover or don’t cover” question, and many cardiometabolic care conversations remain focused on individual conditions, rather than complex evolving multi-condition needs. A more complete strategy helps members before, during, and after a GLP-1 prescription––and that happens with a nuanced approach to behavior change, personalized guidance, and ongoing support. In other words, a real strategy adapts to members’ real lives, as opposed to assuming everyone’s medication adherence is perfect. 

Join this session to learn three design principles that can set a cardiometabolic program apart: giving members meaningful agency and choice, providing personalized and timely guidance, and offering support that adapts to real life.
Woman taking picture of

In this session, the speakers will cover

  • A framework for evaluating cardiometabolic and GLP-1 benefit strategies in 2027
  • How chronic conditions overlap in an employer population and how fragmented approaches make care harder
  • A practical framework for evaluating GLP-1 value beyond pharmacy spend
Register Today!

Speakers

Rajiv Roy, MD, ABIM, ABOM Diabetes & Metabolism Endocrinologist

Rajiv Roy, MD, ABIM, ABOM

Diabetes & Metabolism Endocrinologist

Dr. Rajiv Roy is a dual board-certified endocrinologist and obesity medicine specialist who has been in practice for over 20 years. He is an expert in the management of diabetes and obesity and has been recognized as one of the Top Doctors in San Diego Magazine as voted by his peers. He practices at a large multi-specialty group and regularly lectures on these conditions.

Britt Buntman VP, Cardiometabolic, Omada Health

Britt Buntman

VP, Cardiometabolic, Omada Health

During more than a decade at Omada, Britt has helped build and lead many teams and capabilities, including Customer Success, Payer Access and Alliances, Corporate Strategy, and most recently our Cardiometabolic team and business. In her role as VP, Cardiometabolic, Britt leads a team dedicated to building, studying, and enhancing our GLP-1 and cardiometabolic strategy and programs as well as bringing them to market to serve our partners, customers, and members.

Kevin Masci, PharmD Senior Director, Clinical Affairs, Omada Health

Kevin Masci, PharmD

Senior Director, Clinical Affairs, Omada Health

Kevin has two decades of healthcare expertise as a licensed pharmacist with leadership roles across a variety of practice settings from Retail, PBM, to Health Systems. His previous experience includes Amazon Pharmacy, CVS Health, Prime Therapeutics, and Target, where his focus was Patient Safety and Clinical Quality programs enhancing patient outcomes and streamlining the experience. Today, Kevin ensures that Omada’s programs adhere to the highest industry standards with an emphasis on clinical rigor.